Top compounds associated with response to TDRD10


Feature Type Standardized
Nominal ANOVA
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.095 0.005
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.009
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA 17-AAG CCLE pan-cancer AAC -0.11 0.02
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.077 0.02
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.07 0.02
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.03
mRNA MG-132 CTRPv2 pan-cancer AAC 0.13 0.03
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.21 0.03
Download CSV